MASSACHUSETTS FINANCIAL SERVICES CO /MA/
Position in GILD — Gilead Sciences, Inc.
CIK 912938
Boston, MA
Position in GILD
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$875,467,841
+$357,099,512 QoQ
Shares Held
6,281,609
+48.7% QoQ
Ownership
0.506%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 75.99460584063733.ToString("F0")%
Shared 19.472319910392386.ToString("F0")%
None 4.533074248970288.ToString("F0")%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $7,300,763,534 across 12 Drug Manufacturers - General names. GILD ranks #4 (12.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
13,434,302 | $3,283,880,778 | |
| 2 | PFE |
Pfizer Inc
|
56,911,830 | $1,598,084,183 | |
| 3 | ABBV |
AbbVie Inc.
|
5,610,330 | $1,220,190,668 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
6,281,609 | $875,467,841 | |
| 5 | BIIB |
Biogen Inc.
|
720,629 | $132,112,911 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,050,815 | $63,731,927 | |
| 7 | NVS |
Novartis AG
|
246,655 | $37,676,550 | |
| 8 | MRK |
Merck & Co., Inc.
|
271,829 | $32,698,308 |
All Filings in GILD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $875,467,841 | 6,281,609 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $518,368,329 | 4,223,304 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $12,132,855 | 109,305 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $12,671,440 | 114,291 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $10,564,745 | 94,286 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $7,012,545 | 75,918 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $6,322,122 | 75,407 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $5,887,010 | 85,804 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $6,246,906 | 85,282 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $6,884,796 | 84,987 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $20,875,284 | 278,560 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $21,219,835 | 275,332 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $31,843,884 | 383,800 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $45,891,974 | 534,560 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $34,827,889 | 564,563 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $35,604,288 | 576,028 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $33,540,380 | 564,178 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $18,926,157 | 260,655 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $12,461,936 | 178,410 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $31,810,976 | 461,966 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $26,904,369 | 416,283 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $25,011,424 | 429,307 | Shares | Defined | 2021-05-12 | |
| 2020-09-30 | $22,520,409 | 356,392 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||